Open AccessPATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTS
Author(s) -
Е. О. Таратухин,
Н. В. Теплова
Publication year - 2013
Publication title -
kardiovaskulârnaâ terapiâ i profilaktika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.158
H-Index - 16
eISSN - 2619-0125
pISSN - 1728-8800
DOI - 10.15829/1728-8800-2013-2-85-88
Subject(s) - hypervolemia , medicine , calcium , calcium channel , pathogenesis , peripheral resistance , pathophysiology of hypertension , vascular resistance , pharmacology , cardiology , intensive care medicine , blood pressure , cardiac output , blood volume
The paper describes the key aspects of arterial hypertension pathogenesis and the relevant therapeutic strategies. The authors discuss the role of increased peripheral vascular resistance and hypervolemia as factors which can be targeted by calcium channel blockers. The new evidence on this medication class, including the third-generation calcium antagonists, is presented.